SJG Clinical Research Consultancy Ltd 09738770 false 2025-08-01 2026-07-31 2026-07-31 The principal activity of the company is clinical reseach consultancy Digita Accounts Production Advanced 6.30.9574.0 true 09738770 2025-08-01 2026-07-31 09738770 2026-07-31 09738770 core:CurrentFinancialInstruments core:WithinOneYear 2026-07-31 09738770 bus:Micro-entities 2025-08-01 2026-07-31 09738770 bus:AuditExemptWithAccountantsReport 2025-08-01 2026-07-31 09738770 bus:FullAccounts 2025-08-01 2026-07-31 09738770 bus:SmallCompaniesRegimeForAccounts 2025-08-01 2026-07-31 09738770 bus:RegisteredOffice 2025-08-01 2026-07-31 09738770 bus:Director1 2025-08-01 2026-07-31 09738770 bus:PrivateLimitedCompanyLtd 2025-08-01 2026-07-31 09738770 bus:Agent1 2025-08-01 2026-07-31 09738770 countries:AllCountries 2025-08-01 2026-07-31 09738770 2024-08-01 2025-07-31 09738770 2025-07-31 09738770 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 iso4217:GBP xbrli:pure

Registration number: 09738770

SJG Clinical Research Consultancy Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 July 2026

 

SJG Clinical Research Consultancy Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

SJG Clinical Research Consultancy Ltd

Company Information

Director

Dr S J Gray

Registered office

Cart House 2
Copley Hill Business Park
Cambridge Road
Babraham
Cambridge
CB22 3GN

Accountants

Tim Phillips & Co Ltd
AccountantsCart House 2
Copley Hill Business Park
Cambridge Road
Babraham
Cambridge
CB22 3GN

 

SJG Clinical Research Consultancy Ltd

(Registration number: 09738770)
Balance Sheet as at 31 July 2026

2026
£

2025
£

Current assets

17,691

32,979

Creditors: Amounts falling due within one year

-

1

Total assets less current liabilities

17,691

32,980

Accruals and deferred income

(810)

(762)

 

16,881

32,218

Capital and reserves

16,881

32,218

1

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2025 - 1).

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the director on 13 August 2026
 

.........................................
Dr S J Gray
Director

For the financial year ending 31 July 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.